Revised January 2013
HIV Prevention for Drug-Involved Offenders During Reentry (HIV Prevention)
PI: James Inciardi, Ph.D. (R37DA006124)
HIV Prevention for Drug-Involved Offenders During Reentry was designed to address the prevalence of HIV/HCV/HBV within the community corrections offender population. The study examined the effectiveness of a HIV/HCV/HBV intervention protocol and was designed to learn how it is integrated into community corrections. The approach was a multi-media prevention intervention utilizing an interactive DVD and workbook tailored to specific gender and ethnic groups and risk behaviors.
Specific study aims included:
- Collecting HIV, HCV and HBV risk behavior information.
- Implement and evaluate the effectiveness of a newly refined HIV/HCV/HBV prevention/intervention protocol (the CJ Targeted Intervention).
- Determine the relative effectiveness of the interventions when delivered by a certified HIV peer interventionist counselor.
- Integrate HIV/HCV/HBV prevention into the post-release community supervision process.
- Examine how intervention delivery is affected by different organizational structures and orientations.
Restructuring Risky Relationships-HIV (RRR-HIV)
PI: Carl Leukefeld, Ph.D. (R01DA011580)
This project examined a HIV intervention addressing women’s HIV risks. The overall goal of this project was to develop an HIV intervention for criminal justice involved female drug abusers who are re-entering the community. The intervention focused on reducing HIV behaviors by restructuring relationship thinking errors to help women make safer decisions about risky HIV related behaviors.
The following specific aims organized the project:
- Develop the RRR-HIV intervention manual which incorporates relationships, thinking errors, and HIV related risky behaviors.
- Pilot the RRR-HIV intervention to examine the content and feasibility of delivery.
- Evaluate the intervention manual using an experimental two group design
Outlines NIDA’s drug abuse and addiction research strategic priorities for the next 5 years, focusing on prevention, treatment, HIV/AIDS, and other cross-cutting issues.